Results 171 to 180 of about 157,713 (224)

Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension

, 2004
Hossein A. Ghofrani, Joanna Pepke‐Żaba, Joan Albert Barberá, Richard N. Channick, Anne Keogh, Miguel Ángel Gómez‐Sánchez, Meinhard Kneußl, Friedrich Grimminger   +7 more
openalex   +1 more source

Sex‐related pathophysiological mechanisms may be present before symptoms of HFpEF develop

ESC Heart Failure, EarlyView.
Abstract Aims Understanding sex‐related cardiovascular differences in those with pre‐HFpEF (asymptomatic with normal ejection fraction, elevated natriuretic peptides and structural or functional heart disease) could help explain why females are more likely to develop symptomatic HFpEF compared with males.
B. Wong, J.D. Dodd, J. Gallagher, B. Dyer, C. Ryan, K. McDonald, M. Ledwidge   +6 more
wiley   +1 more source

Treatment algorithm for pulmonary arterial hypertension. [PDF]

Eur Respir J
Chin KM, Gaine SP, Gerges C, Jing ZC, Mathai SC, Tamura Y, McLaughlin VV, Sitbon O.   +7 more
europepmc   +1 more source

Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis. [PDF]

Pharmaceuticals (Basel)
Tonello S, D'Onghia D, Di Ruscio A, Mora SM, Vincenzi F, Caria G, Fracchia A, Vercellino N, Bussolati B, Tanzi A, Rizzi M, Minisini R, Sola D, Scacchi M, Mai S, Pirisi M, Smirne C, Grossini E, Cantaluppi V, Comi C, Murdaca G, Colangelo D, Sainaghi PP.   +22 more
europepmc   +1 more source

Right ventricular dysfunction for prediction of long‐term recovery in de novo HFrEF : a PROLONG‐II substudy

ESC Heart Failure, EarlyView.
Abstract Aims To analyse the predictive value of advanced markers of right ventricular (RV) function and RV‐pulmonary arterial (PA) coupling in forecasting long‐term left ventricular (LV) improvement in de novo heart failure with reduced ejection fraction (HFrEF).
Aiste Monika Jakstaite, Johanna Mueller‐Leisse, Henrike A.K. Hillmann, Stephan Hohmann, Jörg Eiringhaus, Udo Bavendiek, Tibor Kempf, Christian Veltmann, Johann Bauersachs, David Duncker, D. Berliner   +10 more
wiley   +1 more source

Physical exercise for pulmonary arterial hypertension diagnosis and therapy. [PDF]

Int J Cardiol Congenit Heart Dis
Lwin M, Masding A, McCabe C.
europepmc   +1 more source

STRIDE 1: Effects of the Selective ETA Receptor Antagonist, Sitaxsentan Sodium, in a Patient Population with Pulmonary Arterial Hypertension that meets Traditional Inclusion Criteria of Previous Pulmonary Arterial Hypertension Trials

, 2004
David Langleben, Tommy A. Brock, Richard A. F. Dixon, Robyn J. Barst   +3 more
openalex   +1 more source

Cardiac magnetic resonance left atrioventricular coupling index as a prognostic tool in hypertrophic cardiomyopathy

ESC Heart Failure, EarlyView.
Abstract Aims A novel marker left atrioventricular coupling index (LACI) has been proved to be associated with cardiovascular events in patients without history of cardiovascular disease. However, the studies on cardiac magnetic resonance‐derived LACI in hypertrophic cardiomyopathy (HCM) patients are limited, and the prognostic value of LACI has still ...
Jinyang Wen, Junhao Tu, Xinwei Tao, Yuanyuan Tang, Zhaoxia Yang, Ziyi Pan, Yi Luo, Chunlin Xiang, Dazhong Tang, Lu Huang, Liming Xia   +10 more
wiley   +1 more source